| SLD | Name: | (3Z)-N-[(4E)-5-(4-{(5S)-5-[(acetylamino)methyl]-2-oxo-1,3-oxazolidin-3-yl}-2-fluorophenyl)pent-4-en-1-yl]-3-(4-methyl-2,6-dioxo-1,6-dihydropyrimidin-5(2H)-ylidene)propanamide | Formula: | C25 H28 F N5 O6 | SMILES: | O=C(NCC3OC(=O)N(c2ccc(/C=C/CCCNC(=O)C/C=C1/C(=NC(=O)NC1=O)C)c(F)c2)C3)C | InChi: | InChI=1S/C25H28FN5O6/c1-15-20(23(34)30-24(35)29-15)9-10-22(33)27-11-5-3-4-6-17-7-8-18(12-21(17)26)31-14-19(37-25(31)36)13-28-16(2)32/h4,6-9,12,19H,3,5,10-11,13-14H2,1-2H3,(H,27,33)(H,28,32)(H,30,34,35)/b6-4+,20-9-/t19-/m0/s1 | Definition date: | 2008-07-16 | Last modified: | 2011-06-04 | Identifier: | (3Z)-N-[(4E)-5-(4-{(5S)-5-[(acetylamino)methyl]-2-oxo-1,3-oxazolidin-3-yl}-2-fluorophenyl)pent-4-en-1-yl]-3-(4-methyl-2,6-dioxo-1,6-dihydropyrimidin-5(2H)-ylidene)propanamide |
|
| RSF | Name: | (3R,3aS,6aR)-hexahydrofuro[2,3-b]furan-3-ol | Formula: | C6 H10 O3 | SMILES: | OC1COC2OCCC12 | InChi: | InChI=1S/C6H10O3/c7-5-3-9-6-4(5)1-2-8-6/h4-7H,1-3H2/t4-,5-,6+/m0/s1 | Definition date: | 2008-10-16 | Last modified: | 2011-06-04 | Identifier: | (3R,3aS,6aR)-hexahydrofuro[2,3-b]furan-3-ol |
|
| SLF | Name: | SULFATE-3-D-GALACTOSYL-BETA-1-1-N-STEAROYL-D-SPHINGOSINE | Formula: | C42 H81 N O11 S | SMILES: | O=S(=O)(O)OC1C(O)C(OC(OCC(NC(=O)CCCCCCCCCCCCCCCCC)C(O)/C=C/CCCCCCCCCCCCC)C1O)CO | InChi: | InChI=1S/C42H81NO11S/c1-3-5-7-9-11-13-15-17-18-20-22-24-26-28-30-32-38(46)43-35(36(45)31-29-27-25-23-21-19-16-14-12-10-8-6-4-2)34-52-42-40(48)41(54-55(49,50)51)39(47)37(33-44)53-42/h29,31,35-37,39-42,44-45,47-48H,3-28,30,32-34H2,1-2H3,(H,43,46)(H,49,50,51)/b31-29+/t35-,36+,37+,39-,40+,41-,42+/m0/s1 | Definition date: | 2003-03-20 | Last modified: | 2011-06-04 | Identifier: | N-[(1S,2R,3E)-2-hydroxy-1-{[(3-O-sulfo-beta-D-galactopyranosyl)oxy]methyl}heptadec-3-en-1-yl]octadecanamide |
|
| 89I | Name: | 5-[4-(DIMETHYLAMINO)PHENYL]-6-[(6-MORPHOLIN-4-YLPYRIDIN-3-YL)ETHYNYL]PYRIMIDIN-4-AMINE | Formula: | C23 H24 N6 O | SMILES: | n3cc(C#Cc2ncnc(N)c2c1ccc(N(C)C)cc1)ccc3N4CCOCC4 | InChi: | InChI=1S/C23H24N6O/c1-28(2)19-7-5-18(6-8-19)22-20(26-16-27-23(22)24)9-3-17-4-10-21(25-15-17)29-11-13-30-14-12-29/h4-8,10,15-16H,11-14H2,1-2H3,(H2,24,26,27) | Definition date: | 2006-08-30 | Last modified: | 2011-06-04 | Identifier: | 5-[4-(dimethylamino)phenyl]-6-[(6-morpholin-4-ylpyridin-3-yl)ethynyl]pyrimidin-4-amine |
|
| SLI | Name: | 2-hydroxy-N-phenylbenzamide | Formula: | C13 H11 N O2 | SMILES: | Oc1ccccc1C(=O)Nc2ccccc2 | InChi: | InChI=1S/C13H11NO2/c15-12-9-5-4-8-11(12)13(16)14-10-6-2-1-3-7-10/h1-9,15H,(H,14,16) | Definition date: | 2010-02-15 | Last modified: | 2011-06-04 | Identifier: | 2-hydroxy-N-phenyl-benzamide |
|
| RSM | Name: | (2S)-2-(acetylamino)-N-methyl-4-[(R)-methylsulfinyl]butanamide | Formula: | C8 H16 N2 O3 S | SMILES: | O=C(NC(C(=O)NC)CCS(=O)C)C | InChi: | InChI=1S/C8H16N2O3S/c1-6(11)10-7(8(12)9-2)4-5-14(3)13/h7H,4-5H2,1-3H3,(H,9,12)(H,10,11)/t7-,14+/m0/s1 | Definition date: | 2009-06-01 | Last modified: | 2011-06-04 | Identifier: | (2S)-2-(acetylamino)-N-methyl-4-[(R)-methylsulfinyl]butanamide |
|
| QKV | Name: | (6-bromo-1'H,4H-spiro[1,3-benzodioxine-2,4'-piperidin]-1'-yl)methanol | Formula: | C13 H16 Br N O3 | SMILES: | Brc2ccc1OC3(OCc1c2)CCN(CO)CC3 | InChi: | InChI=1S/C13H16BrNO3/c14-11-1-2-12-10(7-11)8-17-13(18-12)3-5-15(9-16)6-4-13/h1-2,7,16H,3-6,8-9H2 | Definition date: | 2011-02-02 | Last modified: | 2011-06-04 | Identifier: | (6-bromo-1'H,4H-spiro[1,3-benzodioxine-2,4'-piperidin]-1'-yl)methanol |
|
| RSO | Name: | R-STYRENE OXIDE | Formula: | C8 H8 O | SMILES: | O2C(c1ccccc1)C2 | InChi: | InChI=1S/C8H8O/c1-2-4-7(5-3-1)8-6-9-8/h1-5,8H,6H2/t8-/m0/s1 | Definition date: | 2003-08-12 | Last modified: | 2011-06-04 | Identifier: | (2R)-2-phenyloxirane |
|
| KU8 | Name: | 4-[3-(1,4-diazepan-1-ylcarbonyl)-4-fluorobenzyl]phthalazin-1(2H)-one | Formula: | C21 H21 F N4 O2 | SMILES: | O=C(N1CCNCCC1)c2cc(ccc2F)CC4=NNC(=O)c3ccccc34 | InChi: | InChI=1S/C21H21FN4O2/c22-18-7-6-14(12-17(18)21(28)26-10-3-8-23-9-11-26)13-19-15-4-1-2-5-16(15)20(27)25-24-19/h1-2,4-7,12,23H,3,8-11,13H2,(H,25,27) | Definition date: | 2008-01-31 | Last modified: | 2011-06-04 | Identifier: | 4-[3-(1,4-diazepan-1-ylcarbonyl)-4-fluorobenzyl]phthalazin-1(2H)-one |
|
| NA3 | Name: | (3S)-3-{[(5-BROMOPYRIDIN-3-YL)CARBONYL]AMINO}-4-OXOBUTANOIC ACID | Formula: | C10 H9 Br N2 O4 | SMILES: | O=C(c1cncc(Br)c1)NC(C=O)CC(=O)O | InChi: | InChI=1S/C10H9BrN2O4/c11-7-1-6(3-12-4-7)10(17)13-8(5-14)2-9(15)16/h1,3-5,8H,2H2,(H,13,17)(H,15,16)/t8-/m0/s1 | Definition date: | 2003-11-07 | Last modified: | 2011-06-04 | Identifier: | (3S)-3-{[(5-bromopyridin-3-yl)carbonyl]amino}-4-oxobutanoic acid |
|
| NA4 | Name: | 4-[5-(2-CARBOXY-1-FORMYL-ETHYLCARBAMOYL)-PYRIDIN-3-YL]-BENZOIC ACID | Formula: | C17 H14 N2 O6 | SMILES: | O=C(O)CC(C=O)NC(=O)c2cncc(c1ccc(C(=O)O)cc1)c2 | InChi: | InChI=1S/C17H14N2O6/c20-9-14(6-15(21)22)19-16(23)13-5-12(7-18-8-13)10-1-3-11(4-2-10)17(24)25/h1-5,7-9,14H,6H2,(H,19,23)(H,21,22)(H,24,25)/t14-/m0/s1 | Definition date: | 2003-11-19 | Last modified: | 2011-06-04 | Identifier: | 4-(5-{[(1S)-2-carboxy-1-formylethyl]carbamoyl}pyridin-3-yl)benzoic acid |
|
| SLR | Name: | (3R,4R)-3-hydroxy-2-[(1S)-1-hydroxy-2-methylpropyl]-4-methyl-5-oxo-D-proline | Formula: | C10 H17 N O5 | SMILES: | O=C1NC(C(=O)O)(C(O)C1C)C(O)C(C)C | InChi: | InChI=1S/C10H17NO5/c1-4(2)6(12)10(9(15)16)7(13)5(3)8(14)11-10/h4-7,12-13H,1-3H3,(H,11,14)(H,15,16)/t5-,6+,7-,10-/m1/s1 | Definition date: | 2008-07-29 | Last modified: | 2011-06-04 | Identifier: | (3R,4R)-3-hydroxy-2-[(1S)-1-hydroxy-2-methylpropyl]-4-methyl-5-oxo-D-proline |
|
| SLU | Name: | 5'-O-[N-(DEHYDROLUCIFERYL)-SULFAMOYL] ADENOSINE | Formula: | C21 H18 N8 O8 S3 | SMILES: | O=S(=O)(OCC3OC(n1c2ncnc(N)c2nc1)C(O)C3O)NC(=O)c4nc(sc4)c5nc6ccc(O)cc6s5 | InChi: | InChI=1S/C21H18N8O8S3/c22-16-13-17(24-6-23-16)29(7-25-13)21-15(32)14(31)11(37-21)4-36-40(34,35)28-18(33)10-5-38-19(27-10)20-26-9-2-1-8(30)3-12(9)39-20/h1-3,5-7,11,14-15,21,30-32H,4H2,(H,28,33)(H2,22,23,24)/t11-,14-,15-,21-/m1/s1 | Definition date: | 2005-09-06 | Last modified: | 2011-06-04 | Identifier: | 5'-O-({[2-(6-hydroxy-1,3-benzothiazol-2-yl)-1,3-thiazol-4-yl]carbonyl}sulfamoyl)adenosine |
|
| RSX | Name: | (4aS,7aR)-octahydro-1H-cyclopenta[b]pyridine-6,6-diylbis(phosphonic acid) | Formula: | C8 H17 N O6 P2 | SMILES: | O=P(O)(O)C2(CC1C(NCCC1)C2)P(=O)(O)O | InChi: | InChI=1S/C8H17NO6P2/c10-16(11,12)8(17(13,14)15)4-6-2-1-3-9-7(6)5-8/h6-7,9H,1-5H2,(H2,10,11,12)(H2,13,14,15)/t6-,7+/m0/s1 | Definition date: | 2008-04-03 | Last modified: | 2011-06-04 | Identifier: | (4aS,7aR)-octahydro-1H-cyclopenta[b]pyridine-6,6-diylbis(phosphonic acid) |
|
| RF2 | Name: | 3-(4-fluorophenyl)-5-phenyl-4H-1,2,4-triazole | Formula: | C14 H10 F N3 | SMILES: | Fc3ccc(c2nnc(c1ccccc1)n2)cc3 | InChi: | InChI=1S/C14H10FN3/c15-12-8-6-11(7-9-12)14-16-13(17-18-14)10-4-2-1-3-5-10/h1-9H,(H,16,17,18) | Definition date: | 2009-02-03 | Last modified: | 2011-06-04 | Identifier: | 3-(4-fluorophenyl)-5-phenyl-4H-1,2,4-triazole |
|
| RF3 | Name: | 1-(thiophen-2-ylacetyl)-4-(3-thiophen-2-yl-1,2,4-oxadiazol-5-yl)piperidine | Formula: | C17 H17 N3 O2 S2 | SMILES: | O=C(N3CCC(c1onc(n1)c2sccc2)CC3)Cc4sccc4 | InChi: | InChI=1S/C17H17N3O2S2/c21-15(11-13-3-1-9-23-13)20-7-5-12(6-8-20)17-18-16(19-22-17)14-4-2-10-24-14/h1-4,9-10,12H,5-8,11H2 | Definition date: | 2009-02-03 | Last modified: | 2011-06-04 | Identifier: | 1-(thiophen-2-ylacetyl)-4-(3-thiophen-2-yl-1,2,4-oxadiazol-5-yl)piperidine |
|
| NAB | Name: | 2-((4'-HYDROXYNAPHTHYL)-AZO)BENZOIC ACID | Formula: | C17 H12 N2 O3 | SMILES: | O=C(O)c3ccccc3/N=N/c2c1ccccc1c(O)cc2 | InChi: | InChI=1S/C17H12N2O3/c20-16-10-9-15(11-5-1-2-6-12(11)16)19-18-14-8-4-3-7-13(14)17(21)22/h1-10,20H,(H,21,22)/b19-18+ | Definition date: | 1999-07-08 | Last modified: | 2011-06-04 | Identifier: | 2-[(E)-(4-hydroxynaphthalen-1-yl)diazenyl]benzoic acid |
|
| NAD | Name: | NICOTINAMIDE-ADENINE-DINUCLEOTIDE | Formula: | C21 H27 N7 O14 P2 | SMILES: | NC(=O)c1ccc[n+](c1)[CH]2O[CH](CO[P]([O-])(=O)O[P](O)(=O)OC[CH]3O[CH]([CH](O)[CH]3O)n4cnc5c(N)ncnc45)[CH](O)[CH]2O | InChi: | InChI=1S/C21H27N7O14P2/c22-17-12-19(25-7-24-17)28(8-26-12)21-16(32)14(30)11(41-21)6-39-44(36,37)42-43(34,35)38-5-10-13(29)15(31)20(40-10)27-3-1-2-9(4-27)18(23)33/h1-4,7-8,10-11,13-16,20-21,29-32H,5-6H2,(H5-,22,23,24,25,33,34,35,36,37)/t10-,11-,13-,14-,15-,16-,20-,21-/m1/s1 | Definition date: | 1999-07-08 | Last modified: | 2011-06-04 | Identifier: | [(2R,3S,4R,5R)-5-(3-aminocarbonylpyridin-1-ium-1-yl)-3,4-dihydroxy-oxolan-2-yl]methyl [[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxy-oxolan-2-yl]methoxy-hydroxy-phosphoryl] phosphate |
|
| SM1 | Name: | N-(BENZYLSULFONYL)-D-SERYL-N-(4-{[AMINO(IMINO)METHYL]AMINO}BENZYL)-L-ALANINAMIDE | Formula: | C21 H28 N6 O5 S | SMILES: | O=S(=O)(NC(C(=O)NC(C(=O)NCc1ccc(NC(=[N@H])N)cc1)C)CO)Cc2ccccc2 | InChi: | InChI=1S/C21H28N6O5S/c1-14(19(29)24-11-15-7-9-17(10-8-15)26-21(22)23)25-20(30)18(12-28)27-33(31,32)13-16-5-3-2-4-6-16/h2-10,14,18,27-28H,11-13H2,1H3,(H,24,29)(H,25,30)(H4,22,23,26)/t14-,18+/m0/s1 | Definition date: | 2004-06-15 | Last modified: | 2011-06-04 | Identifier: | N-(benzylsulfonyl)-D-seryl-N-(4-carbamimidamidobenzyl)-L-alaninamide |
|
| NAE | Name: | NICOTINAMIDE ADENINE DINUCLEOTIDE ACETONE ADDUCT | Formula: | C24 H31 N7 O15 P2 | SMILES: | CC(=O)Cc1cc[n+](cc1C(N)=O)[CH]2O[CH](CO[P]([O-])(=O)O[P](O)(=O)OC[CH]3O[CH]([CH](O)[CH]3O)n4cnc5c(N)ncnc45)[CH](O)[CH]2O | InChi: | InChI=1S/C24H31N7O15P2/c1-10(32)4-11-2-3-30(5-12(11)21(26)37)23-18(35)16(33)13(44-23)6-42-47(38,39)46-48(40,41)43-7-14-17(34)19(36)24(45-14)31-9-29-15-20(25)27-8-28-22(15)31/h2-3,5,8-9,13-14,16-19,23-24,33-36H,4,6-7H2,1H3,(H5-,25,26,27,28,37,38,39,40,41)/t13-,14-,16-,17-,18-,19-,23-,24-/m1/s1 | Definition date: | 1999-07-08 | Last modified: | 2011-06-04 | Identifier: | [(2R,3S,4R,5R)-5-[3-aminocarbonyl-4-(2-oxopropyl)pyridin-1-ium-1-yl]-3,4-dihydroxy-oxolan-2-yl]methyl [[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxy-oxolan-2-yl]methoxy-hydroxy-phosphoryl] phosphate |
|
| SM2 | Name: | (1R)-1-(2-THIENYLACETYLAMINO)-1-(3-CARBOXYPHENYL)METHYLBORONIC ACID | Formula: | C14 H14 B N O5 S | SMILES: | O=C(NC(B(O)O)c1cc(C(=O)O)ccc1)Cc2sccc2 | InChi: | InChI=1S/C14H14BNO5S/c17-12(8-11-5-2-6-22-11)16-13(15(20)21)9-3-1-4-10(7-9)14(18)19/h1-7,13,20-21H,8H2,(H,16,17)(H,18,19)/t13-/m0/s1 | Definition date: | 2002-10-23 | Last modified: | 2011-06-04 | Identifier: | 3-{(R)-(dihydroxyboranyl)[(thiophen-2-ylacetyl)amino]methyl}benzoic acid |
|
| SM3 | Name: | (1R)-1-(2-THIENYLACETYLAMINO)-1-PHENYLMETHYLBORONIC ACID | Formula: | C13 H14 B N O3 S | SMILES: | O=C(NC(B(O)O)c1ccccc1)Cc2sccc2 | InChi: | InChI=1S/C13H14BNO3S/c16-12(9-11-7-4-8-19-11)15-13(14(17)18)10-5-2-1-3-6-10/h1-8,13,17-18H,9H2,(H,15,16)/t13-/m0/s1 | Definition date: | 2002-10-23 | Last modified: | 2011-06-04 | Identifier: | {(R)-phenyl[(thiophen-2-ylacetyl)amino]methyl}boronic acid |
|
| SM5 | Name: | (1E)-5-(1-piperidin-4-yl-3-pyridin-4-yl-1H-pyrazol-4-yl)-2,3-dihydro-1H-inden-1-one oxime | Formula: | C22 H23 N5 O | SMILES: | n4c(c1ccncc1)c(c3ccc2C(=NO)CCc2c3)cn4C5CCNCC5 | InChi: | InChI=1S/C22H23N5O/c28-26-21-4-2-16-13-17(1-3-19(16)21)20-14-27(18-7-11-24-12-8-18)25-22(20)15-5-9-23-10-6-15/h1,3,5-6,9-10,13-14,18,24,28H,2,4,7-8,11-12H2/b26-21+ | Definition date: | 2008-06-05 | Last modified: | 2011-06-04 | Identifier: | (1E)-5-(1-piperidin-4-yl-3-pyridin-4-yl-1H-pyrazol-4-yl)-2,3-dihydro-1H-inden-1-one oxime |
|
| RT8 | Name: | NALPHA-[(TRANS-4-METHYLCYCLOHEXYL)CARBONYL]-N-PYRIDIN-4-YL-D-TRYPTOPHANAMIDE | Formula: | C24 H28 N4 O2 | SMILES: | O=C(Nc1ccncc1)C(NC(=O)C2CCC(C)CC2)Cc4c3ccccc3nc4 | InChi: | InChI=1S/C24H28N4O2/c1-16-6-8-17(9-7-16)23(29)28-22(24(30)27-19-10-12-25-13-11-19)14-18-15-26-21-5-3-2-4-20(18)21/h2-5,10-13,15-17,22,26H,6-9,14H2,1H3,(H,28,29)(H,25,27,30)/t16-,17-,22-/m1/s1 | Definition date: | 2010-04-16 | Last modified: | 2011-06-04 | Identifier: | Nalpha-[(trans-4-methylcyclohexyl)carbonyl]-N-pyridin-4-yl-D-tryptophanamide |
|
| SM7 | Name: | 6-[1-(piperidin-4-yl)-3-(pyridin-4-yl)-1H-pyrazol-4-yl]indeno[1,2-c]pyrazole | Formula: | C23 H20 N6 | SMILES: | N6=NC=5C(C=C4C=5C=CC(c1cn(nc1c2ccncc2)C3CCNCC3)=C4)=C6 | InChi: | InChI=1S/C23H20N6/c1-2-20-17(12-18-13-26-27-22(18)20)11-16(1)21-14-29(19-5-9-25-10-6-19)28-23(21)15-3-7-24-8-4-15/h1-4,7-8,11-14,19,25H,5-6,9-10H2 | Definition date: | 2010-12-07 | Last modified: | 2011-06-04 | Identifier: | 6-[1-(piperidin-4-yl)-3-(pyridin-4-yl)-1H-pyrazol-4-yl]indeno[1,2-c]pyrazole |
|